| Vinod Tony Kannarkat, MD | |
|
4695 Macarthur Ct # 1112a, Newport Beach, CA 92660-1882 | |
| (949) 642-5513 | |
| (949) 642-9479 |
| Full Name | Vinod Tony Kannarkat |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 19 Years |
| Location | 4695 Macarthur Ct # 1112a, Newport Beach, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891966412 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | A 103084 (California) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jmc Medical Corporation | 7618364928 | 2 |
News Archive
University of Delaware researchers have some good news and some bad news that could help you in those critical, decisive moments.
Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis' and Debiopharm's August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.
Avita Medical Ltd., the regenerative medicine company, is pleased to announce that it has successfully completed the transfer and acquisition of intellectual property currently licensed through the McComb Foundation of Western Australia.
Polymer Group, Inc. today announced it has entered into a definitive agreement to be acquired by an affiliate of Blackstone Capital Partners V L.P. This transaction is the result of the strategic review process initiated by PGI on April 7, 2010, and is expected to close prior to the end of the first quarter of 2011.
› Verified 6 days ago
| Entity Name | Hoag Memorial Hospital Presbyterian |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518951300 PECOS PAC ID: 5799677860 Enrollment ID: O20040325000901 |
News Archive
University of Delaware researchers have some good news and some bad news that could help you in those critical, decisive moments.
Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis' and Debiopharm's August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.
Avita Medical Ltd., the regenerative medicine company, is pleased to announce that it has successfully completed the transfer and acquisition of intellectual property currently licensed through the McComb Foundation of Western Australia.
Polymer Group, Inc. today announced it has entered into a definitive agreement to be acquired by an affiliate of Blackstone Capital Partners V L.P. This transaction is the result of the strategic review process initiated by PGI on April 7, 2010, and is expected to close prior to the end of the first quarter of 2011.
› Verified 6 days ago
| Entity Name | Emanuel Shaoulian Md Cardiology & Research Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538425285 PECOS PAC ID: 4183889256 Enrollment ID: O20120625000113 |
News Archive
University of Delaware researchers have some good news and some bad news that could help you in those critical, decisive moments.
Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis' and Debiopharm's August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.
Avita Medical Ltd., the regenerative medicine company, is pleased to announce that it has successfully completed the transfer and acquisition of intellectual property currently licensed through the McComb Foundation of Western Australia.
Polymer Group, Inc. today announced it has entered into a definitive agreement to be acquired by an affiliate of Blackstone Capital Partners V L.P. This transaction is the result of the strategic review process initiated by PGI on April 7, 2010, and is expected to close prior to the end of the first quarter of 2011.
› Verified 6 days ago
| Entity Name | Jmc Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003562398 PECOS PAC ID: 7618364928 Enrollment ID: O20220504002212 |
News Archive
University of Delaware researchers have some good news and some bad news that could help you in those critical, decisive moments.
Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis' and Debiopharm's August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.
Avita Medical Ltd., the regenerative medicine company, is pleased to announce that it has successfully completed the transfer and acquisition of intellectual property currently licensed through the McComb Foundation of Western Australia.
Polymer Group, Inc. today announced it has entered into a definitive agreement to be acquired by an affiliate of Blackstone Capital Partners V L.P. This transaction is the result of the strategic review process initiated by PGI on April 7, 2010, and is expected to close prior to the end of the first quarter of 2011.
› Verified 6 days ago
| Entity Name | Care Connectors Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902386642 PECOS PAC ID: 0143685461 Enrollment ID: O20230420000918 |
News Archive
University of Delaware researchers have some good news and some bad news that could help you in those critical, decisive moments.
Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis' and Debiopharm's August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.
Avita Medical Ltd., the regenerative medicine company, is pleased to announce that it has successfully completed the transfer and acquisition of intellectual property currently licensed through the McComb Foundation of Western Australia.
Polymer Group, Inc. today announced it has entered into a definitive agreement to be acquired by an affiliate of Blackstone Capital Partners V L.P. This transaction is the result of the strategic review process initiated by PGI on April 7, 2010, and is expected to close prior to the end of the first quarter of 2011.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vinod Tony Kannarkat, MD 520 Superior Ave Ste 255, Newport Beach, CA 92663-3668 Ph: (949) 642-5513 | Vinod Tony Kannarkat, MD 4695 Macarthur Ct # 1112a, Newport Beach, CA 92660-1882 Ph: (949) 642-5513 |
News Archive
University of Delaware researchers have some good news and some bad news that could help you in those critical, decisive moments.
Curis, Inc., announced today that its licensee Debiopharm S.A. has received approval from France's regulatory authority Agence Française de Securité Sanitaire des Produits de Santé (AFSSAPS) of a Clinical Trial Application (CTA) for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of Curis' and Debiopharm's August 2009 license agreement, Curis will receive an $8 million milestone payment from Debiopharm for the achievement of this development objective.
Avita Medical Ltd., the regenerative medicine company, is pleased to announce that it has successfully completed the transfer and acquisition of intellectual property currently licensed through the McComb Foundation of Western Australia.
Polymer Group, Inc. today announced it has entered into a definitive agreement to be acquired by an affiliate of Blackstone Capital Partners V L.P. This transaction is the result of the strategic review process initiated by PGI on April 7, 2010, and is expected to close prior to the end of the first quarter of 2011.
› Verified 6 days ago
Dr. Sevitlana Safaei, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 520 Superior Ave, Ste 205, Newport Beach, CA 92663 Phone: 949-650-2462 Fax: 949-650-1366 | |
Dr. Jin-hwa Simon, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Hoag Dr, Newport Beach, CA 92663 Phone: 949-610-7245 Fax: 657-241-7720 | |
Brian Kong, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Hoag Dr, Newport Beach, CA 92663 Phone: 949-610-7245 Fax: 657-241-7720 | |
Dr. Cesar Balbin Guerrero, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 350 Vista Madera, Newport Beach, CA 92660 Phone: 949-270-6371 | |
Nhat Tran, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Hoag Dr, Newport Beach, CA 92663 Phone: 949-610-7245 Fax: 657-241-7720 | |
Dr. Leslie Kennerly Meserve, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 400 Newport Center Dr Ste 310, Newport Beach, CA 92660 Phone: 949-558-0501 Fax: 949-558-0502 | |
Bhavini Jashvant Jaiswal, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Hoag Dr, Critical Care Department Box 6100, Newport Beach, CA 92663 Phone: 480-227-1318 |